The Searle Company Limited (PSX:SEARL)
77.90
-0.43 (-0.55%)
At close: Oct 16, 2026
The Searle Company Revenue
In the fiscal year ending June 30, 2026, The Searle Company had annual revenue of 36.81B PKR with 28.70% growth. The Searle Company had revenue of 7.42B in the quarter ending June 30, 2026, with 12.36% growth. That makes The Searle Company the 20,494th largest company in the world by revenue and 115th in Pakistan.
Revenue
36.81B
Revenue Growth
+28.70%
P/S Ratio
1.25
Revenue / Employee
9.91M
Employees
3,715
Market Cap
45.82B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 36.81B | 8.21B | 28.70% |
| Jun 30, 2025 | 28.60B | -800.84M | -2.72% |
| Jun 30, 2024 | 29.40B | 3.60B | 13.97% |
| Jun 30, 2023 | 25.80B | -4.11B | -13.75% |
| Jun 30, 2022 | 29.91B | 3.69B | 14.07% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 77.02B |
| GlaxoSmithKline Pakistan | 67.12B |
| Highnoon Laboratories | 28.50B |
| AGP Limited | 27.70B |
| Ferozsons Laboratories | 23.96B |
| Citi Pharma | 14.08B |
| Macter International | 12.17B |
| Otsuka Pakistan | 4.11B |